FDA Brief

Company record

Konrad Rejdak, M.D., Ph.D.

1 FDA warning letter since 2023 and 0 recalls in the last 12 months.

Get an email the day FDA posts anything new about Konrad Rejdak, M.D., Ph.D..

Warning letters

  1. Konrad Rejdak, M.D., Ph.D.

    FDA warns Dr. Konrad Rejdak over clinical trial data integrity failures in a CIDP immune globulin study.

    Medium